RxDoctor Payments Data

Jessicah Todd, APRN

Family · Columbia, SCNPI 1689450835

Payments from drug & device makers

$727in general payments, 2019–2025

Across 40 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$125
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$89
  • Exact Sciences$68
  • AbbVie$61
  • Pfizer$49
  • Bayer$42
  • plus $293 from 14 others

What the payments were for

  • Food & beverage$727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$727 in reported general payments places this provider in the 60th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$89,299
Medicare patients
245
Services billed
1,522

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide19$23,752
OzempicSemaglutide21$19,747
EliquisApixaban21$15,920
FarxigaDapagliflozin Propanediol13$12,369
Albuterol Sulfate HfaAlbuterol Sulfate59$1,542
Ondansetron OdtOndansetron17$1,236
Metoprolol Succinate38$777
Rosuvastatin Calcium74$737
Levothyroxine Sodium83$673
Gabapentin52$608
Omeprazole39$586
Clonazepam27$567
Trazodone Hcl19$537
Atorvastatin Calcium64$472
Losartan Potassium47$382

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$14$23,75219 claims
Novo NordiskOzempic$125$19,74721 claims
PfizerEliquis$49$15,92021 claims
AstraZenecaFarxiga$16$12,36913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,248 family providers in South Carolina.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →